International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
Tests May Predict Chemo Benefit in Breast Cancer
2
FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma
3
ctDNA Levels May Predict Treatment Response in Advanced Breast Cancer
4
Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor
5